HNI CORP (HNI) received a notice that retired CEO David Sylvester intends to sell shares of its common stock under Rule 144, with the sales stated as being made pursuant to a 10b5-1 trading plan.
The notice lists planned sales of 18,612 shares and 5,829 shares of common stock that were acquired as stock bonuses from the issuer, to be sold for cash. It also reports that Sylvester sold 559 shares of HNI common stock during the prior three months for $26,476.95.
HNI CORP (symbol: HNI) is the issuer of record for a Form 4 filing submitted to the SEC. Tasi Irene reported acquisition or exercise transactions in this Form 4 filing.
HNI CORP (HNI) reported that officer Irene Tasi received a compensation-related grant of 12,409 shares of common stock in the form of restricted stock units (RSUs) on September 14, 2026 under the HNI Corporation Incentive Compensation Plan for Legacy Steelcase Employees. The grant consists of 5,985 RSUs vesting in three equal annual installments starting February 20, 2027, and 6,424 RSUs vesting in two equal annual installments starting September 14, 2027, in each case subject to her continued service on the applicable vesting dates. Each RSU represents a contingent right to receive one share of HNI common stock.
HNI CORP (HNI) filed an initial ownership report for officer Irene Tasi, who is identified as an officer with the title President, Steelcase. The filing reports no beneficial ownership positions or transactions in HNI securities at this time and notes an exhibit for a Power of Attorney.
HNI CORP (HNI) received a Form 144 notice indicating that retired CEO David Sylvester may sell 559 shares of HNI common stock. The shares are listed on the NYSE, with an aggregate market value of $26,476.95 as of September 11, 2026.
The notice cites sales being made pursuant to a Rule 10b5-1 trading plan. It also lists prior stock bonus awards of 427 shares on February 28, 2025 and 132 shares on February 27, 2026 that relate to the securities to be sold.
HNI CORP (HNI) President & CEO Jeffrey D. Lorenger reported an options exercise and share sale. On August 28, 2026, he exercised 1,504 non‑qualifying employee stock options at an exercise price of $38.68 per share, receiving 1,504 shares of common stock, then sold those 1,504 shares at $50.00 per share. The filing notes the transactions were effected pursuant to a Rule 10b5-1 plan adopted on February 27, 2026. Following the exercise, he held 27,048 options directly and indirect common stock holdings of 313,061.462 shares by trust and 7,674.193 shares through a Profit Sharing Retirement Plan.
HNI CORP (HNI) is the issuer for a planned sale of its common stock by insider Jeffrey D. Lorenger under Rule 144. A brokerage account at Fidelity Brokerage Services LLC has filed to sell 1,504 shares of HNI common stock, related to a stock option exercise for cash dated August 28, 2026. The notice also lists several prior sales of HNI common shares by Lorenger during the past three months, with disclosed share amounts and dollar values.
HNI CORP (HNI) reported insider transactions by President & CEO Jeffrey D. Lorenger involving option exercises and related stock sales over August 26–27, 2026. Lorenger exercised non‑qualifying employee stock options at an exercise price of $38.68 per share and received HNI common stock, then sold an equal number of shares in multiple open‑market transactions at weighted average prices of about $50 per share. The filing states these trades were effected under a Rule 10b5‑1 trading plan adopted on February 27, 2026. The report also notes indirect holdings of HNI common stock held by a trust and under a profit sharing retirement plan.
HNI CORP (HNI) received a notice that company officer/director Jeffrey D. Lorenger intends to sell common stock under Rule 144. The notice covers up to 39,576 shares of HNI common stock, with an aggregate market value of $1,982,336.81, based on NYSE trading as of 08/27/2026. These shares were acquired from the issuer via stock option exercise for cash on the same date.
In addition, Lorenger reports prior sales of HNI common stock during the past three months: 45,850 shares for $2,180,204.18 on 08/03/2026, 700 shares for $35,005.01 on 08/24/2026, and 7,508 shares for $375,867.43 on 08/26/2026. Shares of HNI common stock outstanding were reported as 72,181,800.
HNI CORP (HNI) has a Rule 144 notice filed for planned sales of its common stock by Jeffrey D. Lorenger. The notice states that 7,508 shares of HNI common stock are to be sold on 08/26/2026, in connection with a stock option exercise, through Fidelity Brokerage Services LLC for cash.
The filing also lists prior sales of HNI common stock for this account during the past three months: 45,850 shares on 08/03/2026 for proceeds of $2,180,204.05 and 700 shares on 08/24/2026 for $35,005.00. The notice is signed by Daniel Tucci as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Jeffrey D. Lorenger.
HNI CORP (HNI) reported that President & CEO Jeffrey D. Lorenger exercised employee stock options for a total of 700 shares of common stock at an exercise price of $38.68 per share on August 24, 2026, and sold the same 700 shares at weighted-average prices of about $50.00 per share. The sales were effected pursuant to a Rule 10b5-1 plan adopted on February 27, 2026. Following these transactions, Lorenger reports indirect holdings of 313,061.462 shares held by a trust and 7,674.193 shares through a Profit Sharing Retirement Plan.